Skip to content
Aperlena
Free alerts

TED - Tenders Electronic Daily (Publications Office of the EU) verified 13 minutes ago Contract notice

Czech Republic - Antineoplastics and immunomodulators - Antineoplastics 2026

Original Česko - Antineoplastika a imunomodulátory - Antineoplastika 2026

Open Czechia Jihozápad Medical equipment & pharmaceuticals

Buyer Fakultní nemocnice Plzeň

32 days left

Key facts

Closes
09:00 (UTC+1)
Estimated value
€10.0M
€9,981,191 · converted from CZK
Competition
Open race
  1. Published
  2. Today
  3. Deadline open for 31 days
  4. Awarded pending

Bidding window

31 days from publication to deadline

Usual length

Notices of this kind (Czechia, open procedure, above the EU threshold) give a median of 31 days, half of them between 28 and 34 days, based on 20,461 notices of the last two years.

This buyer usually gives 31 days (median of its last 98 calls for tender).

View the official notice Watch this tender
Add to calendar

If the deadline moves or the notice is corrected, we email you. Log in

The Aperlena Verdict

Open race

No supplier dominates: 56 different companies have won the last 67 comparable contracts from this buyer over 5 years. This is a genuinely open race.

Expected final price vs the published estimate
-15.7%

Based on 67 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.

Summary

Machine-generated summary

The contract covers the supply of medicinal products for the therapy of malignant diseases, with a total estimated volume of 12,680 individual doses. The medicines are intended for healthcare provided at University Hospital Pilsen (FN Plzen). Deliveries will be made for four years from signing the purchase contract, based on the outcome of the completed tender procedure. The products include vials containing 600 mg or 1200 mg pertuzumab with 600 mg trastuzumab (ATC L01FY01), vials of 1400 mg or 1600 mg rituximab (ATC L01FA01), oral forms of 200 mg entrectinib (ATC L01EX14) and vials of 30 mg or 140 mg polatuzumab vedotin (ATC L01FX14).

Description

Předmětem veřejné zakázky jsou dodávky léčivých přípravků určených pro terapii zhoubných onemocnění v celkovém předpokládaném objemu 12 680 jednotlivých dávek léčivých přípravků. Přípravky jsou určeny pro poskytování zdravotní péče na zdravotnických pracovištích FN Plzeň. Dodávky předmětu plnění budou realizovány na základě výsledků ukončeného zadávacího řízení po dobu čtyř let od podpisu kupní smlouvy. Ampule s obsahem 600 mg pertuzumabu a 600 mg trastuzumabu, předpokládaný roční objem 740 ampulí (dávek); ampule s obsahem 1200 mg pertuzumabu a 600 mg trastuzumabu, předpokládaný roční objem 60 ampulí (dávek); ATC L01FY01; Ampule s obsahem 1 400 mg rituximabu, předpokládaný roční objem 90 ampulí (dávek); ampule s obsahem 1 600 mg rituximabu, předpokládaný roční objem 40 ampulí (dávek); ATC L01FA01; P.o. forma s obsahem 200 mg entrektinibu v jednotce formy, předpokládaný roční objem 1 800 jednotek formy (dávek); ATC L01EX14; Ampule s obsahem 30 mg polatuzumab vedotinu, předpokládaný roční objem 380 ampulí (dávek); ampule s obsahem 140 mg polatuzumab vedotinu, předpokládaný roční objem 60 ampulí (dávek); ATC L01FX14

Bid or no-bid?

Six questions before you commit a team. Under each one, what the register holds on it. The answers are yours.

  1. In your favour:

    Do we meet every eligibility criterion?

    Open procedure: any interested supplier may submit a bid.

    Above the EU threshold: open to companies from any EU country.

  2. Your call:

    Can we deliver this with the team we have?

    Estimated at €10.0M.

  3. Your call:

    Do we have two comparable references?

    Comparable work is in Medical equipment & pharmaceuticals.

  4. In your favour:

    Is the deadline realistic for a proper offer?

    32 days left, 24 of them working days.

  5. Check this first:

    Is there a margin at the likely winning price?

    This buyer usually awards this kind of contract for between €310,555 and €6.8M.

    Contracts here close a median of 15.7% below their estimate.

  6. In your favour:

    Do we know this buyer?

    56 different companies won the last 67 comparable contracts.

Can I bid?

  • Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
  • The notice is written in Czech.
  • Certificates from another EU country? Check the equivalents on eCertis

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 13 minutes ago

View the official notice

What this buyer has paid before

Based on 67 comparable contracts this buyer awarded in this sector over the last 4 years.

This notice
€10.0M
Median award
€1.6M
Middle half of past awards
€310,555 to €6.8M

The estimate is larger than three in four past awards.

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

The buyer

Full buyer profile

Fakultní nemocnice Plzeň

Czechia

notices in the register
224
awards
122
awarded in total
€415.4M

Who wins its contracts

Many suppliers
different companies won its awards
83
of the awards went to the three most frequent winners
9%
of its calls state an estimated value
100%

Based on 104 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.

Who usually wins this buyer's contracts in this sector

Company Wins Total awarded Last win
KLARO, spol. s r.o. 3 €29,131 May 2026
Janssen-Cilag s.r.o. 2 €19.0M Aug 2026
PHOENIX lékárenský velkoobchod, s.r.o.; Amgen s.r.o.; Alliance Healthcare s.r.o.; Takeda Pharmaceuticals Czech Republic s.r.o. 2 €16.8M Apr 2025
Bristol-Myers Squibb spol. s r.o. 2 €16.8M Nov 2025
Gilead Sciences s.r.o. 2 €11.3M Jan 2026

Based on 67 awards with a linked company profile over the last 5 years.

11 open tenders right now

Market context

Larger than 93% of the open notices in Medical equipment & pharmaceuticals across Europe.

open now in Medical equipment & pharmaceuticals
10,834
median open notice
€142,690

Who wins in this market

Many suppliers

Czechia · Medical equipment & pharmaceuticals

different companies won awards here
1,117
of the awards went to the three most frequent winners
19%
buyers awarded contracts here
173

Based on 4,728 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Similar tenders

Open now

Awarded before

Never miss a tender like this

3,866 new notices in Medical equipment & pharmaceuticals in Czechia in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

32 days left

Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector

Index

Close
Log in

Language